KEYTRUDA Plus LENVIMA Now an Option for Endometrial Carcinoma Patients in Europe
source: pixabay.com

KEYTRUDA Plus LENVIMA Now an Option for Endometrial Carcinoma Patients in Europe

European patients with recurrent or advanced endometrial carcinoma have a new treatment option, as the European Commission (EC) has approved KEYTRUDA plus LENVIMA. Approval is specifically for adult patients whose…

Continue Reading KEYTRUDA Plus LENVIMA Now an Option for Endometrial Carcinoma Patients in Europe
New 2.25 Million Dollar Grant will Support Gene Therapy Research for Alport Syndrome
source: pixabay.com

New 2.25 Million Dollar Grant will Support Gene Therapy Research for Alport Syndrome

Doctor Jeffrey Miner, who is a member of the Alport Syndrome Foundation's (ASF) Scientific Advisory Research Network, was just awarded a Ro1 grant worth 2.25 million dollars for his research in Alport…

Continue Reading New 2.25 Million Dollar Grant will Support Gene Therapy Research for Alport Syndrome